Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Recruiting
200 enrolled
ReAL
Recruiting
5,000 enrolled
EUREKA
Recruiting
400 enrolled
ProDigALIty
Recruiting
760 enrolled
Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Recruiting
400 enrolled
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Recruiting
2,000 enrolled
TRANSFORMM
Recruiting
1,000 enrolled
Study of CAR-T Therapy in Older Patients
Recruiting
154 enrolled
Predicting Response to Selinexor-Based Therapy in Relapsed/Refractory Multiple Myeloma: A Multicenter Prospective Study
Recruiting
127 enrolled
Dara-PD in the Treatment of Patients With First Relapse of Multiple Myeloma
Recruiting
50 enrolled
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Active not recruiting
656 enrolled
ITA-WebNet
Recruiting
1,000 enrolled
Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
Recruiting
48 enrolled
B-SCR-MM
Recruiting
5,000 enrolled
MED-hATTR
Completed
37 enrolled
Rapid dFLC Response Predict CHR in AL Amyloidosis
Recruiting
50 enrolled
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Terminated
50 enrolled
GlycAL
Recruiting
100 enrolled
ALPS
Recruiting
100 enrolled
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
Active not recruiting
69 enrolled
Biomarkers of AKI in Patients Receiving Daratumumab
Completed
20 enrolled
BE.Amycon Biobank & Data Registry UZ Leuven
Recruiting
505 enrolled
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Recruiting
700 enrolled
A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders
Active not recruiting
49 enrolled
SPOTLIGHT
Recruiting
100 enrolled
Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
Active not recruiting
192 enrolled
AI
Enrolling by invitation
10 enrolled
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Recruiting
10,000 enrolled
NICHE
Recruiting
2,300 enrolled
DynaFiT
Recruiting
131 enrolled
GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma
Recruiting
210 enrolled
Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research
Not yet recruiting
200 enrolled
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
Active not recruiting
50 enrolled
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Completed
56 enrolled
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
Active not recruiting
153 enrolled
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Recruiting
500 enrolled
iCaRe2
Recruiting
999,999 enrolled
CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study
Recruiting
1,665 enrolled
Institutional Registry of Rare Diseases
Recruiting
380 enrolled
NIRVANA
Completed
36 enrolled
GA-ACT
Recruiting
208 enrolled
QOL-ONE PRO-CT
Not yet recruiting
162 enrolled
Anonymization of Clinical Data From Pseudonymized Databases Collected as Part of Previus Clinical Trials on Multiple Myeloma
Not yet recruiting
600 enrolled
CARE-Heme
Recruiting
5,000 enrolled
iPREFER
Completed
9 enrolled
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Recruiting
10,000 enrolled
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Recruiting
30,000 enrolled
LIBERATE
Recruiting
2,500 enrolled
Covid-19 Vaccine Responsiveness in MM and Waldenstrom
Completed
146 enrolled